Case Study Series – Regulatory Acceptability of Virtual Visits
Case Study Series – Regulatory Acceptability of Virtual Visits Case Studies on Regulatory Acceptance of Virtual Site Visits in Clinical Trials Introduction: Regulatory Shift Toward Virtual Oversight The evolution of decentralized clinical trials has propelled virtual site visits from an emergency workaround during the COVID-19 pandemic to a long-term solution for remote oversight. However, regulatory…
Read More “Case Study Series – Regulatory Acceptability of Virtual Visits” »